More direct evidence for the contribution of C to tissue damage was obtained from postmortem analysis of two lung and three skin biopsy specimens of COVID-19 patients that revealed deposits of C activation products C4d, C3d, and C5b-9 in the lung inter-alveolar septal microvessels and in the skin vasculature [20]. This evidence concerns the gene C5 and COVID-19.